Because the majority of the patients enroled in our study were patients with stage II/III colorectal carcinoma, a clinical investigation in patients with stage IV colorectal carcinoma is required to affirm the relationship between RHBDD1 and tumor metastasis, and a further study is needed if that is the case. This evidence concerns the gene RHBDD1 and neoplasm.